Published in Drug Week, October 10th, 2003
Increasing evidence now shows, however, that new classes of drugs, such as the NMDA receptor antagonist memantine, can help patients with moderately severe to severe dementia.
The most recent evidence comes from a 166-patient study of people with dementia, known by doctors as the M-BEST trial (Benefit and Efficacy in Severely demented patients during Treatment with Memantine). This supports data from other studies carried out in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.